Skip to content
Crystal Blackjack House

Users Stopping Anti-Obesity Medications Put On Weight Far More Rapidly Than Those on Conventional Diets

Image of pharmaceutical injection and scale
Weight management often requires long-term strategies.

A recent study suggests that individuals who stop using popular GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who stop traditional diet and exercise plans.

Findings released in a prominent health publication points out that while overweight people frequently drop substantial amounts of their total mass while on the medication, the mass returns at an average rate of nearly a kilo each month upon discontinuation.

"People purchasing these medications need to be cognizant of the danger of quick weight regain when the medication ends," warns expert Dr. Susan Jebb.

That rate of regain implies a return to original mass within about 18 months.

Comparing Treatments

The analysis, which looked at 37 of trials involving thousands of participants, contrasted the effects of these new drugs with conventional dieting.

The team note that individuals who lose weight through dieting generally see a more gradual creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Quick Rebound

Experts believe the mechanism of the injections is key to understanding the amplified weight return.

These medications mimic a body's own chemical called GLP-1, which controls feelings of fullness.

"Artificially providing the hormone levels far above than normal could lead to the system to produce less of its own natural hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making overeating far more likely."

A Lifelong Condition?

The NHS recommend the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

A number of clinicians argue that, due to the high risk of relapse, the treatment might need to be life-long.

This opinion is echoed by drug manufacturers, who state that the findings "underscore the long-term character of excess weight," akin to managing conditions like hypertension.

User Testimonies

Individuals who have discontinued the medication report a powerful return of cravings.

"It felt as if something flipping and you become extremely hungry," said one woman.

This difficulty is exacerbated if patients have not developed sustainable lifestyle or habit changes during therapy.

Widespread Adoption

Survey data show that millions of people in the UK have tried these injections in the last 12 months, with interest being substantial.

  • Use is more common among women than males.
  • The 40s and 50s demographic shows the greatest level of interest.
  • A large proportion access the drugs through private healthcare rather than the NHS.

Ultimately, researchers emphasize that while these medications are effective agents for shedding pounds, they are not a magic cure and long-term success hinges on ongoing behavioural management.

Written by

Tamara Morrison

A professional blackjack strategist with over a decade of experience in casino gaming and player education.

Crystal Blackjack House

Type to search articles.